日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Aptamer-based search for correlates of plasma and serum water T(2): implications for early metabolic dysregulation and metabolic syndrome

基于适体筛选血浆和血清水T2相关因素:对早期代谢紊乱和代谢综合征的意义

Patel, Vipulkumar; Dwivedi, Alok K; Deodhar, Sneha; Mishra, Ina; Cistola, David P

Trends and Prevalence of the Metabolic Syndrome Among US Adults

美国成年人代谢综合征的趋势和患病率

Abohashem, Shady; Hassan, Ibrahim; Wasfy, Jason H; Taub, Pam R

IMPROVE-DiCE, a 2-Part, Open-Label, Phase 2a Trial Evaluating the Safety and Effectiveness of Ninerafaxstat in Patients With Cardiometabolic Syndromes

IMPROVE-DiCE 是一项分为两部分、开放标签的 2a 期试验,旨在评估 Ninerafaxstat 在心血管代谢综合征患者中的安全性和有效性。

Hundertmark, Moritz J; Birkhoelzer, Sarah M; Portwood, Clara; Siu, Adrienne G; Matthews, Violet; Lewis, Andrew J; Grist, James; Mózes, Ferenc; Henry, John A; Patel, Jai; Chamberlin, Paul; Sarwar, Rizwan; Yavari, Arash; Dehbi, Hakim-Moulay; Rao, Prashant; Shi, Xu; Zheng, Shuning; Robbins, Jeremy M; Gerszten, Robert E; Frenneaux, Michael P; Valkovič, Ladislav; Miller, Jack J J J; Neubauer, Stefan; Tyler, Damian J; Rider, Oliver J

Lifestyle Intervention for Sustained Remission of Metabolic Syndrome: A Randomized Clinical Trial

生活方式干预对代谢综合征持续缓解的影响:一项随机临床试验

Powell, Lynda H; Berkley-Patton, Jannette; Drees, Betty M; Karavolos, Kelly; Lohse, Barbara; Masters, Kevin S; Nicklas, Jacinda M; Rothschild, Steven K; Yeh, Chen; Zimmermann, Laura J; Suzuki, Sumihiro

Adipocyte NADH dehydrogenase reverses circadian and diet-induced metabolic syndrome.

脂肪细胞 NADH 脱氢酶可逆转昼夜节律和饮食引起的代谢综合征。

Hepler Chelsea, Waldeck Nathan J, Weidemann Benjamin J, Marcheva Biliana, Chen You-Jia, Hecker Jacqueline, Zhu Ziming, Nozawa Rino, Mastroni Joseph V, Thorne Anneke K, Reczek Colleen R, Cedernaes Jonathan, Ramsey Kathryn M, Peek Clara B, Barish Grant D, Chandel Navdeep S, Bass Joseph

Reply to correspondence on "Impacts of metabolic syndrome diseases on long-term outcomes of chronic hepatitis B patients treated with nucleos(t)ide analogues"

回复关于“代谢综合征疾病对接受核苷(酸)类似物治疗的慢性乙型肝炎患者长期预后的影响”的来信

Jang, Heejoon; Kim, Won

Correspondence to editorial 1 on "Impacts of metabolic syndrome diseases on long-term outcomes of chronic hepatitis B patients treated with nucleos(t)ide analogues"

致编辑1的信函,主题为“代谢综合征疾病对接受核苷(酸)类似物治疗的慢性乙型肝炎患者长期预后的影响”

Huang, Rui; Nguyen, Mindie H

Correspondence to editorial 2 on "Impacts of metabolic syndrome diseases on long-term outcomes of chronic hepatitis B patients treated with nucleos(t)ide analogues"

致编辑2的信函,主题为“代谢综合征疾病对接受核苷(酸)类似物治疗的慢性乙型肝炎患者长期预后的影响”

Huang, Rui; Nguyen, Mindie H

Metabolic health in antiviral era of chronic hepatitis B: Editorial on "Impacts of metabolic syndrome diseases on long-term outcomes of chronic hepatitis B patients treated with nucleos(t)ide analogues"

慢性乙型肝炎抗病毒时代的代谢健康:关于“代谢综合征疾病对接受核苷(酸)类似物治疗的慢性乙型肝炎患者长期预后的影响”的社论

Huang, Shang-Chin; Kao, Jia-Horng

Type 2 diabetes as a key metabolic risk factor for adverse outcomes in nucleos(t)ide analogue-treated chronic hepatitis B: Editorial on "Impacts of metabolic syndrome diseases on long-term outcomes of chronic hepatitis B patients treated with nucleos(t)ide analogues"

2型糖尿病是核苷(酸)类似物治疗慢性乙型肝炎患者不良预后的关键代谢危险因素:关于“代谢综合征疾病对核苷(酸)类似物治疗慢性乙型肝炎患者长期预后的影响”的社论

Jang, Heejoon; Kim, Won